427 related articles for article (PubMed ID: 33914267)
1. The Protective A673T Mutation of Amyloid Precursor Protein (APP) in Alzheimer's Disease.
Xia Q; Yang X; Shi J; Liu Z; Peng Y; Wang W; Li B; Zhao Y; Xiao J; Huang L; Wang D; Gao X
Mol Neurobiol; 2021 Aug; 58(8):4038-4050. PubMed ID: 33914267
[TBL] [Abstract][Full Text] [Related]
2. The protective mutation A673T in amyloid precursor protein gene decreases Aβ peptides production for 14 forms of Familial Alzheimer's Disease in SH-SY5Y cells.
Guyon A; Rousseau J; Lamothe G; Tremblay JP
PLoS One; 2020; 15(12):e0237122. PubMed ID: 33370284
[TBL] [Abstract][Full Text] [Related]
3. Protective Alzheimer's disease-associated APP A673T variant predominantly decreases sAPPβ levels in cerebrospinal fluid and 2D/3D cell culture models.
Wittrahm R; Takalo M; Kuulasmaa T; Mäkinen PM; Mäkinen P; Končarević S; Fartzdinov V; Selzer S; Kokkola T; Antikainen L; Martiskainen H; Kemppainen S; Marttinen M; Jeskanen H; Rostalski H; Rahunen E; Kivipelto M; Ngandu T; Natunen T; Lambert JC; Tanzi RE; Kim DY; Rauramaa T; Herukka SK; Soininen H; Laakso M; Pike I; Leinonen V; Haapasalo A; Hiltunen M
Neurobiol Dis; 2023 Jun; 182():106140. PubMed ID: 37120095
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of Alzheimer disease protection by the A673T allele of amyloid precursor protein.
Maloney JA; Bainbridge T; Gustafson A; Zhang S; Kyauk R; Steiner P; van der Brug M; Liu Y; Ernst JA; Watts RJ; Atwal JK
J Biol Chem; 2014 Nov; 289(45):30990-1000. PubMed ID: 25253696
[TBL] [Abstract][Full Text] [Related]
5. Investigation of an amyloid precursor protein protective mutation (A673T) in a North American case-control sample of late-onset Alzheimer's disease.
Bamne MN; Demirci FY; Berman S; Snitz BE; Rosenthal SL; Wang X; Lopez OL; Kamboh MI
Neurobiol Aging; 2014 Jul; 35(7):1779.e15-6. PubMed ID: 24529499
[TBL] [Abstract][Full Text] [Related]
6. A mutation in APP protects against Alzheimer's disease and age-related cognitive decline.
Jonsson T; Atwal JK; Steinberg S; Snaedal J; Jonsson PV; Bjornsson S; Stefansson H; Sulem P; Gudbjartsson D; Maloney J; Hoyte K; Gustafson A; Liu Y; Lu Y; Bhangale T; Graham RR; Huttenlocher J; Bjornsdottir G; Andreassen OA; Jönsson EG; Palotie A; Behrens TW; Magnusson OT; Kong A; Thorsteinsdottir U; Watts RJ; Stefansson K
Nature; 2012 Aug; 488(7409):96-9. PubMed ID: 22801501
[TBL] [Abstract][Full Text] [Related]
7. Alternative Selection of β-Site APP-Cleaving Enzyme 1 (BACE1) Cleavage Sites in Amyloid β-Protein Precursor (APP) Harboring Protective and Pathogenic Mutations within the Aβ Sequence.
Kimura A; Hata S; Suzuki T
J Biol Chem; 2016 Nov; 291(46):24041-24053. PubMed ID: 27687728
[TBL] [Abstract][Full Text] [Related]
8. A mutation protective against Alzheimer's disease renders amyloid β precursor protein incapable of mediating neurotoxicity.
Hashimoto Y; Matsuoka M
J Neurochem; 2014 Jul; 130(2):291-300. PubMed ID: 24646423
[TBL] [Abstract][Full Text] [Related]
9. Absence of A673T amyloid-β precursor protein variant in Alzheimer's disease and other neurological diseases.
Ting SK; Chong MS; Kandiah N; Hameed S; Tan L; Au WL; Prakash KM; Pavanni R; Lee TS; Foo JN; Bei JX; Yu XQ; Liu JJ; Zhao Y; Lee WL; Tan EK
Neurobiol Aging; 2013 Oct; 34(10):2441.e7-8. PubMed ID: 23652020
[TBL] [Abstract][Full Text] [Related]
10. Decreased plasma β-amyloid in the Alzheimer's disease APP A673T variant carriers.
Martiskainen H; Herukka SK; Stančáková A; Paananen J; Soininen H; Kuusisto J; Laakso M; Hiltunen M
Ann Neurol; 2017 Jul; 82(1):128-132. PubMed ID: 28556232
[TBL] [Abstract][Full Text] [Related]
11. Familial L723P Mutation Can Shift the Distribution between the Alternative APP Transmembrane Domain Cleavage Cascades by Local Unfolding of the Ε-Cleavage Site Suggesting a Straightforward Mechanism of Alzheimer's Disease Pathogenesis.
Bocharov EV; Nadezhdin KD; Urban AS; Volynsky PE; Pavlov KV; Efremov RG; Arseniev AS; Bocharova OV
ACS Chem Biol; 2019 Jul; 14(7):1573-1582. PubMed ID: 31180641
[TBL] [Abstract][Full Text] [Related]
12. Novel amyloid precursor protein gene mutation (codon 665Asp) in a patient with late-onset Alzheimer's disease.
Peacock ML; Murman DL; Sima AA; Warren JT; Roses AD; Fink JK
Ann Neurol; 1994 Apr; 35(4):432-8. PubMed ID: 8154870
[TBL] [Abstract][Full Text] [Related]
13. The A673T mutation in the amyloid precursor protein reduces the production of β-amyloid protein from its β-carboxyl terminal fragment in cells.
Kokawa A; Ishihara S; Fujiwara H; Nobuhara M; Iwata M; Ihara Y; Funamoto S
Acta Neuropathol Commun; 2015 Nov; 3():66. PubMed ID: 26531305
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease families with amyloid precursor protein mutations.
Rossor MN; Newman S; Frackowiak RS; Lantos P; Kennedy AM
Ann N Y Acad Sci; 1993 Sep; 695():198-202. PubMed ID: 8239283
[TBL] [Abstract][Full Text] [Related]
15. Generation of a human induced pluripotent stem cell line (LL008 1.4) from a familial Alzheimer's disease patient carrying a double KM670/671NL (Swedish) mutation in APP gene.
Oksanen M; Hyötyläinen I; Voutilainen J; Puttonen KA; Hämäläinen RH; Graff C; Lehtonen Š; Koistinaho J
Stem Cell Res; 2018 Aug; 31():181-185. PubMed ID: 30099334
[TBL] [Abstract][Full Text] [Related]
16. Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer's disease.
Shinohara M; Fujioka S; Murray ME; Wojtas A; Baker M; Rovelet-Lecrux A; Rademakers R; Das P; Parisi JE; Graff-Radford NR; Petersen RC; Dickson DW; Bu G
Brain; 2014 May; 137(Pt 5):1533-49. PubMed ID: 24625695
[TBL] [Abstract][Full Text] [Related]
17. Amyloid precursor protein gene mutations responsible for early-onset autosomal dominant Alzheimer's disease.
Kowalska A
Folia Neuropathol; 2003; 41(1):35-40. PubMed ID: 12862394
[TBL] [Abstract][Full Text] [Related]
18. BACE1 Cleavage Site Selection Critical for Amyloidogenesis and Alzheimer's Pathogenesis.
Zhang S; Wang Z; Cai F; Zhang M; Wu Y; Zhang J; Song W
J Neurosci; 2017 Jul; 37(29):6915-6925. PubMed ID: 28626014
[TBL] [Abstract][Full Text] [Related]
19. Generation of a human induced pluripotent stem cell line (UEFi003-A) carrying heterozygous A673T variant in amyloid precursor protein associated with a reduced risk of Alzheimer's disease.
Rolova T; Wu YC; Koskuvi M; Voutilainen J; Sonninen TM; Kuusisto J; Laakso M; Hämäläinen RH; Koistinaho J; Lehtonen Š
Stem Cell Res; 2020 Oct; 48():101968. PubMed ID: 32911327
[TBL] [Abstract][Full Text] [Related]
20. The molecular bases of Alzheimer's disease and other neurodegenerative disorders.
Maccioni RB; Muñoz JP; Barbeito L
Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
